Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Innovate (VATE) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Innovate's Total Liabilities rose 962.35% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 962.35%. This contributed to the annual value of $1.0 billion for FY2024, which is 1229.77% down from last year.
  • As of Q3 2025, Innovate's Total Liabilities stood at $1.1 billion, which was up 962.35% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Innovate's Total Liabilities peaked at $6.4 billion during Q2 2021, and registered a low of $1.0 billion during Q2 2024.
  • Its 5-year average for Total Liabilities is $1.7 billion, with a median of $1.1 billion in 2022.
  • As far as peak fluctuations go, Innovate's Total Liabilities plummeted by 8250.3% in 2021, and later skyrocketed by 1053.62% in 2022.
  • Over the past 5 years, Innovate's Total Liabilities (Quarter) stood at $1.1 billion in 2021, then grew by 10.54% to $1.2 billion in 2022, then fell by 0.12% to $1.2 billion in 2023, then dropped by 12.3% to $1.0 billion in 2024, then grew by 8.32% to $1.1 billion in 2025.
  • Its Total Liabilities was $1.1 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.0 billion in Q1 2025.